Alpa Laboratories Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Share holding
• Capital structures
• Ratio

Mar ' 23	Mar ' 22	Mar ' 21	Mar ' 20	Mar ' 19

Sources of funds

Owner's fund

Equity share capital

21.04

21.04

21.04

21.04

21.04

Share application money

-

-

-

-

-

Preference share capital

-

-

-

-

-

Reserves & surplus

123.49

110.60

96.48

89.19

84.87

Loan funds

Secured loans

2.59

5.85

0.01

0.19

1.46

Unsecured loans

-

-

-

-

-

Total

147.12

137.49

117.53

110.42

107.37

Uses of funds

Fixed assets

Gross block

33.42

34.39

30.63

30.01

28.75

Less : revaluation reserve

-

-

-

-

-

Less : accumulated depreciation

26.38

25.07

23.42

23.60

22.99

Net block

7.04

9.32

7.21

6.42

5.76

Capital work-in-progress

-

-

1.57

0.81

0.12

Investments

89.60

85.73

61.93

67.61

59.21

Net current assets

Current assets, loans & advances

80.86

70.09

79.52

56.37

63.52

Less : current liabilities & provisions

30.38

27.65

32.70

20.78

21.23

Total net current assets

50.48

42.44

46.82

35.59

42.29

Miscellaneous expenses not written

-

-

-

-

-

Total

147.12

137.49

117.53

110.42

107.37

Notes:

Book value of unquoted investments

6.66

6.17

10.43

56.58

59.21

Market value of quoted investments

-

-

-

-

-

Contingent liabilities

3.25

5.28

5.28

5.75

4.07

Number of equity sharesoutstanding (Lacs)

210.41

210.41

210.41

210.41

210.41